Indications
Therapeutic Asset Ratings
9,920 results matching 1 filter
91,565
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Pevonedistat
Follicular Lymphoma
City of Hope Medical Center
P1
CC
(43)
Pevonedistat
Lymphoplasmacytic Lymphoma
City of Hope Medical Center
P1
CC
(43)
Pevonedistat
Mantle Cell Lymphoma
City of Hope Medical Center
P1
CC
(43)
Pevonedistat
Marginal Zone Lymphoma
City of Hope Medical Center
P1
CC
(43)
Pevonedistat
Non-Hodgkin Lymphoma
City of Hope Medical Center
P1
CC
(43)
Pevonedistat
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
City of Hope Medical Center
P1
CC
(43)
pf-07224826
Endometrial Disorder
Pfizer
P1
CC
(43)
pf-07224826
Liposarcoma
Pfizer
P1
CC
(43)
pf-07263689
Hepatocellular Carcinoma
Pfizer
P1
CC
(43)
pf-07263689
Non-Small Cell Lung Carcinoma
Pfizer
P1
CC
(43)
pf-07263689
Renal Cell Carcinoma
Pfizer
P1
CC
(43)
pf-07265028
Gastroesophageal Junction Adenocarcinoma
Pfizer
P1
CC
(43)
pf-07265028
Head And Neck Squamous Cell Carcinoma
Pfizer
P1
CC
(43)
pf-07799544
Brain Neoplasm
Pfizer
P1
CC
(43)
pf-07799544
Differentiated Thyroid Carcinoma
Pfizer
P1
CC
(43)
pf-07799544
Malignant Glioma
Pfizer
P1
CC
(43)
pf-07799544
Low Grade Glioma
Pfizer
P1
CC
(43)
pf-07799544
Cancer
Pfizer
P1
CC
(43)
pf-07820435
Non-Small Cell Lung Carcinoma
Pfizer
P1
CC
(43)
pf-07820435
Head And Neck Squamous Cell Carcinoma
Pfizer
P1
CC
(43)
pf-07826390
Non-Small Cell Lung Carcinoma
Pfizer
P1
CC
(43)
pf-07826390
Head And Neck Squamous Cell Carcinoma
Pfizer
P1
CC
(43)
pf-07934040
Pancreatic Ductal Adenocarcinoma
Pfizer
P1
CC
(43)
pf-07985045
Pancreatic Ductal Adenocarcinoma
Pfizer
P1
CC
(43)
pf-08046033
Non-Small Cell Lung Carcinoma
Pfizer
P1
CC
(43)
Showing 3826 to 3850 of 9,920 assets
Previous
Page 154 of 397
Next
